EPA Reacts to Coronavirus Concerns With Disinfectant Guidance

SS
Seyfarth Shaw LLP
Contributor
With more than 900 lawyers across 18 offices, Seyfarth Shaw LLP provides advisory, litigation, and transactional legal services to clients worldwide. Our high-caliber legal representation and advanced delivery capabilities allow us to take on our clients’ unique challenges and opportunities-no matter the scale or complexity. Whether navigating complex litigation, negotiating transformational deals, or advising on cross-border projects, our attorneys achieve exceptional legal outcomes. Our drive for excellence leads us to seek out better ways to work with our clients and each other. We have been first-to-market on many legal service delivery innovations-and we continue to break new ground with our clients every day. This long history of excellence and innovation has created a culture with a sense of purpose and belonging for all. In turn, our culture drives our commitment to the growth of our clients, the diversity of our people, and the resilience of our workforce.
The efficacy criteria is based on the ease with which the type of virus is inactivated by the disinfectant.
United States Employment and HR
To print this article, all you need is to be registered or login on Mondaq.com.

Seyfarth Synopsis: As an early and aggressive response to potential threats related to the novel coronavirus disease, now identified as COVID-19, the United States Environmental Protection Agency (EPA) activated its Emerging Viral Pathogen Guidance for Antimicrobial Pesticides (Guidance).

The Guidance, first developed in 2016, provides a process to enable the use of certain EPA-registered disinfectant products against emerging pathogens, such as SARS-CoV-2, the pathogen which causes the disease known as COVID-19, that are not otherwise identified on the product label. If a registrant already holds a "pre-qualified emerging viral pathogen designation," then respecting COVID-19, it can provide an efficacy statement on the efficacy of a product to disinfect SARS-CoV-2 (that is, protect against COVID-19) in technical literature issued to health care facilities and medical providers, and in publicly available resources such as non-label-related websites, consumer information services, and social media sites.

The efficacy criteria is based on the ease with which the type of virus is inactivated by the disinfectant. Specific to SARS-CoV-2, the disinfectant must be EPA-approved as a hospital/healthcare or broad spectrum disinfectant; the disinfectant must already be approved by EPA for one small or one large non-enveloped virus (viruses that are generally more difficult to kill or inactivate); and the EPA-approved label must contain emerging pathogen "terms of registration" language describing the emerging pathogen claims the manufacturer can make. SARS-CoV-2 is an enveloped virus, meaning it has a membrane wrapped around it, which makes it easier to kill with the appropriate disinfectant product than small or large non-enveloped viruses.

Registrants that don't meet the criteria set forth in the Guidance, but who make claims related to inactivation of SARS-CoV-2 may face enforcement actions and stiff penalties for distributing mislabeled pesticides.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

EPA Reacts to Coronavirus Concerns With Disinfectant Guidance

United States Employment and HR
Contributor
With more than 900 lawyers across 18 offices, Seyfarth Shaw LLP provides advisory, litigation, and transactional legal services to clients worldwide. Our high-caliber legal representation and advanced delivery capabilities allow us to take on our clients’ unique challenges and opportunities-no matter the scale or complexity. Whether navigating complex litigation, negotiating transformational deals, or advising on cross-border projects, our attorneys achieve exceptional legal outcomes. Our drive for excellence leads us to seek out better ways to work with our clients and each other. We have been first-to-market on many legal service delivery innovations-and we continue to break new ground with our clients every day. This long history of excellence and innovation has created a culture with a sense of purpose and belonging for all. In turn, our culture drives our commitment to the growth of our clients, the diversity of our people, and the resilience of our workforce.
See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More